MDM2 and lymphoma: We were the first to attempt to target the MDM2-MDM4 E3 complex as an alternative strategy to alter the oncogenic MDM2-MDM4 complex and previously reported that MMRi64 induces p53 accumulation for preferential apoptosis induction in p53-wt leukemia/lymphoma cells (30).